FDA Orange Book · active-ingredient family
Quinidine gluconate
Quinidine gluconate is approved as 3 brand and 13 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:QUINIDINE GLUCONATE · NDA 007529
3
Brand (NDA)
13
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable, tablet, tablet, extended release
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| QUINIDINE GLUCONATERLD | LILLY | NDA 007529 | — | Feb 10, 1989 | |
| QUINAGLUTERLD | BAYER HLTHCARE | NDA 016647 | — | Approved Prior to Jan 1, 1982 | |
| DURAQUIN | WARNER CHILCOTT | NDA 017917 | — | Approved Prior to Jan 1, 1982 |
Generic (ANDA) products (13)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| QUINIDINE GLUCONATE | HIBROW HLTHCARE | ANDA 212589 | AB | Sep 17, 2021 | |
| QUINIDINE GLUCONATE | RISING | ANDA 089894 | — | Dec 15, 1988 | |
| QUINIDINE GLUCONATE | HALSEY | ANDA 089476 | — | Apr 10, 1987 | |
| QUINIDINE GLUCONATE | SUN PHARM INDUSTRIES | ANDA 089338 | AB | Feb 11, 1987 | |
| QUINALAN | CHARTWELL MOLECULAR | ANDA 088081 | — | Feb 10, 1986 | |
| QUINIDINE GLUCONATE | SUPERPHARM | ANDA 089164 | — | Nov 21, 1985 | |
| QUINIDINE GLUCONATE | ASCOT | ANDA 088582 | — | Jun 17, 1985 | |
| QUINIDINE GLUCONATE | CYCLE | ANDA 088431 | — | Jan 06, 1984 | |
| QUINIDINE GLUCONATE | WATSON LABS | ANDA 087785 | — | Jan 24, 1983 | |
| QUINIDINE GLUCONATE | ANI PHARMS | ANDA 087810 | — | Sep 29, 1982 | |
| QUINATIME | WATSON LABS | ANDA 087448 | — | Approved Prior to Jan 1, 1982 | |
| QUINACT | BAYER HLTHCARE | ANDA 085978 | — | Approved Prior to Jan 1, 1982 | |
| QUINACT | BAYER HLTHCARE | ANDA 086099 | — | Approved Prior to Jan 1, 1982 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Quinidine gluconate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

